Back to Journals » Clinical Interventions in Aging » Volume 9

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Total article views   HTML views PDF downloads Totals
9,981 Dovepress* 8,636+ 1,548 10,184
PubMed Central* 1,345 700 2,045
Totals 9,981 2,248 12,229
*Since 4 September 2014
+Since July 2016

View citations on PubMed and Google Scholar